Syapse – Healthcare Data News

May 22, 2024July 5, 2024 Competitor News Product Updates

Syapse Expands Oncology Real-World Data Offerings with Introduction of Syapse Cohorts: Essentials

WEST CHESTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) — Syapse, a leading real-world oncology data company announced the launch of its latest real-world data offering: Syapse Cohorts: Essentials. This new offering expands...

Syapse and FDA Extend Collaboration to Advance the Use of Real-World Data (RWD) and Inform Regulatory Science in Oncology

SAN FRANCISCO, Dec. 05, 2023 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, and the...

November 3, 2022November 4, 2022 Blogs/Publications Competitor News Marketing

Connecting Health Systems and Life Science Researchers To Maximize the Potential of Real-world Evidence.

There needs to be a bigger emphasis and move towards connecting the life science companies who are doing the work of using biomarkers to develop therapies with the health systems...

September 15, 2022September 19, 2022 Collaborations Competitor News Data Partnership Oncology

Syapse Enters Collaboration with Merck Using Real-World Evidence to Better Understand Cancers

SAN FRANCISCO and NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...

August 31, 2022September 2, 2022 Collaborations Competitor News Data Partnership Oncology Product Updates

Syapse and Genesis Research Combine Forces to Offer Real-World Evidence Services and Data to Oncology Innovators

SAN FRANCISCO, Aug. 31, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced that they...

August 18, 2022August 22, 2022 Clinical Trials Collaborations Competitor News Oncology

Science 37 and Syapse Partner to Enable Faster Patient Enrollment in Oncology Clinical Trials

Oncology patients and clinical research sponsors benefit from Syapse’s real-world data intelligence and Science 37’s agile trial operating system to help accelerate the identification and participation of eligible participants August...

July 27, 2022July 31, 2022 Competitor News Fundraising/IPO

Syapse Announces $35 Million Growth Investment with Innovatus Capital Partners to Expand Delivery of Real-World Evidence Through Syapse’s Learning Health Network

SAN FRANCISCO and NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...

June 15, 2022June 16, 2022 Collaborations Competitor News Data Partnership Oncology

Pierian and Syapse Collaborate with Health Systems, Leveraging Data to Power Precision Oncology

June 15, 2022 09:15 AM Eastern Daylight Time ST. LOUIS–(BUSINESS WIRE)–Pierian®, a global leader in advanced clinical genomics technology and services, announced with Syapse®, a leading real-world evidence company, a new joint...

May 27, 2022May 30, 2022 Competitor News RWE Study

Syapse Unveils Two New Studies on Use of Machine Learning on Real-World Data to Identify and Treat Cancer With Precision at ASCO 2022

SAN FRANCISCO, May 27, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced two new...

March 31, 2022April 4, 2022 Competitor News HR

Syapse Announces Changes to Board of Directors, Adding Michael Mentesana and Elevating Frank Williams to Chairman Role

SAN FRANCISCO, March 31, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced that long-time...